Literature DB >> 20441409

Maternal and umbilical serum levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in normal pregnancies and in pregnancies complicated by preeclampsia.

Miğraci Tosun1, Handan Celik, Bahattin Avci, Erhan Yavuz, Tayfun Alper, Erdal Malatyalioğlu.   

Abstract

OBJECTIVES: The aim of this study was to investigate the relationship of maternal and umbilical cord interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-alpha) serum levels with the existence and severity of preeclampsia. A particular objective was the comparison of normal umbilical serum levels to preeclamptic values.
MATERIALS AND METHODS: The study group consisted of 24 patients with third trimester singleton pregnancies complicated by preeclampsia (15 severe and 9 mild preeclampsia). The gestational age-matched 19 healthy pregnant women were compared by study group. Maternal and umbilical serum IL-6, IL-8, and TNF-alpha were calculated by using enzyme-linked immunosorbent assay.
RESULTS: Significantly increased maternal and umbilical serum levels of IL-6, IL-8, and TNF-alpha were found in preeclamptic patient group in comparison with the control group. Maternal serum IL-8 and TNF-alpha concentration were significantly higher in patients with severe preeclampsia than in mild preeclampsia. Increased umbilical serum levels of IL-6 and IL-8 were found in severe preeclampsia than in mild preeclampsia. There were significantly higher levels of maternal serum IL-8 and TNF-alpha in patients with preeclampsia with IUGR than in patients with preeclampsia with normal fetal growth.
CONCLUSION: Our findings suggest that increased concentrations of IL-6, IL-8, and TNF-alpha in the maternal and umbilical serum play a significant role in pathogenesis of preeclampsia. Alterations in maternal and umbilical serum levels of IL-6, IL-8, and TNF-alpha may also play role in preeclampsia complicated by intrauterine growth retardation. These associations may offer insight into the etiology and pathogenesis of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441409     DOI: 10.3109/14767051003774942

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  64 in total

Review 1.  Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.

Authors:  Roberto Romero; Offer Erez; Maik Hüttemann; Eli Maymon; Bogdan Panaitescu; Agustin Conde-Agudelo; Percy Pacora; Bo Hyun Yoon; Lawrence I Grossman
Journal:  Am J Obstet Gynecol       Date:  2017-06-12       Impact factor: 8.661

2.  Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection.

Authors:  Luis M Gomez; Lauren Anton; Shindu K Srinivas; Michal A Elovitz; Samuel Parry
Journal:  Reprod Sci       Date:  2018-12-20       Impact factor: 3.060

3.  Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.

Authors:  Kelly K Ferguson; John D Meeker; Thomas F McElrath; Bhramar Mukherjee; David E Cantonwine
Journal:  Am J Obstet Gynecol       Date:  2016-12-30       Impact factor: 8.661

4.  Association of inflammatory cytokines, lipid peroxidation end products and nitric oxide with the clinical severity and fetal outcome in preeclampsia in Indian women.

Authors:  Devika Tayal; Binita Goswami; S K Patra; Reva Tripathi; Alka Khaneja
Journal:  Indian J Clin Biochem       Date:  2013-04-13

5.  Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Marketa Ondrackova; Petra Pirkova; Andrea Kestlerova; Veronika Novotna; Lucie Hympanova; Ladislav Krofta
Journal:  DNA Cell Biol       Date:  2015-03-31       Impact factor: 3.311

Review 6.  Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation.

Authors:  Vikki M Abrahams; Lawrence W Chamley; Jane E Salmon
Journal:  Arthritis Rheumatol       Date:  2017-07-18       Impact factor: 10.995

7.  NFκB and JNK/MAPK activation mediates the production of major macrophage- or dendritic cell-recruiting chemokine in human first trimester decidual cells in response to proinflammatory stimuli.

Authors:  Min Li; Zhen-Ming Wu; Hui Yang; S Joseph Huang
Journal:  J Clin Endocrinol Metab       Date:  2011-06-15       Impact factor: 5.958

8.  Synthesis of sFlt-1 by platelet-monocyte aggregates contributes to the pathogenesis of preeclampsia.

Authors:  Heather D Major; Robert A Campbell; Robert M Silver; D Ware Branch; Andrew S Weyrich
Journal:  Am J Obstet Gynecol       Date:  2014-01-17       Impact factor: 8.661

9.  Mid-pregnancy circulating immune biomarkers in women with preeclampsia and normotensive controls.

Authors:  Brandie D Taylor; Gong Tang; Roberta B Ness; Jørn Olsen; David M Hougaard; Kristin Skogstrand; James M Roberts; Catherine L Haggerty
Journal:  Pregnancy Hypertens       Date:  2015-11-10       Impact factor: 2.899

10.  STAT3-mediated effects of methyltransferase inhibitor 5-aza-2'-deoxycytidine on preeclampsia.

Authors:  Xiaoli Zhang; Gang Wang; Hui Li; Xiangming Jiang; Xiaoyong Zhao
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.